These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 37864525)

  • 1. Non-abstinent recovery in alcohol use disorder is associated with greater regional cortical volumes than heavy drinking.
    May AC; Meyerhoff DJ; Durazzo TC
    Alcohol Clin Exp Res (Hoboken); 2023 Oct; 47(10):1850-1858. PubMed ID: 37864525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional cortical brain volumes at treatment entry relates to post treatment WHO risk drinking levels in those with alcohol use disorder.
    Durazzo TC; Stephens LH; Kraybill EP; May AC; Meyerhoff DJ
    Drug Alcohol Depend; 2024 Feb; 255():111082. PubMed ID: 38219355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontal Brain N-Acetylaspartate at Treatment Entry is Related to Future WHO Risk Drinking Levels in Individuals with Alcohol Use Disorder.
    May AC; Stephens LH; Kraybill EP; Meyerhoff DJ; Durazzo TC
    J Stud Alcohol Drugs; 2024 Aug; ():. PubMed ID: 39126661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical thickness, surface area, and volume of the brain reward system in alcohol dependence: relationships to relapse and extended abstinence.
    Durazzo TC; Tosun D; Buckley S; Gazdzinski S; Mon A; Fryer SL; Meyerhoff DJ
    Alcohol Clin Exp Res; 2011 Jun; 35(6):1187-200. PubMed ID: 21410483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional cortical thickness recovery with extended abstinence after treatment in those with alcohol use disorder.
    Durazzo TC; Stephens LH; Meyerhoff DJ
    Alcohol; 2024 Feb; 114():51-60. PubMed ID: 37657667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of frontal cortical subregion volumes in alcohol dependent individuals during early abstinence: associations with treatment outcome.
    Durazzo TC; Meyerhoff DJ
    Brain Imaging Behav; 2020 Oct; 14(5):1588-1599. PubMed ID: 31197582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional brain volume changes in alcohol-dependent individuals during early abstinence: associations with relapse following treatment.
    Durazzo TC; Mon A; Gazdzinski S; Meyerhoff DJ
    Addict Biol; 2017 Sep; 22(5):1416-1425. PubMed ID: 27329647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactive effects of chronic cigarette smoking and age on brain volumes in controls and alcohol-dependent individuals in early abstinence.
    Durazzo TC; Mon A; Pennington D; Abé C; Gazdzinski S; Meyerhoff DJ
    Addict Biol; 2014 Jan; 19(1):132-43. PubMed ID: 22943795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial longitudinal magnetic resonance imaging data indicate non-linear regional gray matter volume recovery in abstinent alcohol-dependent individuals.
    Durazzo TC; Mon A; Gazdzinski S; Yeh PH; Meyerhoff DJ
    Addict Biol; 2015 Sep; 20(5):956-67. PubMed ID: 25170881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolite levels in the brain reward pathway discriminate those who remain abstinent from those who resume hazardous alcohol consumption after treatment for alcohol dependence.
    Durazzo TC; Pathak V; Gazdzinski S; Mon A; Meyerhoff DJ
    J Stud Alcohol Drugs; 2010 Mar; 71(2):278-89. PubMed ID: 20230726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional Brain Volume Changes in Alcohol-Dependent Individuals During Short-Term and Long-Term Abstinence.
    Zou X; Durazzo TC; Meyerhoff DJ
    Alcohol Clin Exp Res; 2018 Jun; 42(6):1062-1072. PubMed ID: 29672876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatric, Demographic, and Brain Morphological Predictors of Relapse After Treatment for an Alcohol Use Disorder.
    Durazzo TC; Meyerhoff DJ
    Alcohol Clin Exp Res; 2017 Jan; 41(1):107-116. PubMed ID: 27883214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of abstinence, no heavy drinking days, and a 2-level reduction in World Health Organization drinking levels during treatment for alcohol use disorder in the COMBINE study.
    Wallach JD; Gueorguieva R; Phan H; Witkiewitz K; Wu R; O'Malley SS
    Alcohol Clin Exp Res; 2022 Jul; 46(7):1331-1339. PubMed ID: 35616436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination treatment with varenicline and naltrexone reduces World Health Organization risk drinking levels.
    Nieto SJ; Enders CK; Witkiewitz K; O'Malley SS; Ray LA
    Alcohol Clin Exp Res; 2022 Dec; 46(12):2258-2266. PubMed ID: 36515648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural brain differences in alcohol-dependent individuals with and without comorbid substance dependence.
    Mon A; Durazzo TC; Abe C; Gazdzinski S; Pennington D; Schmidt T; Meyerhoff DJ
    Drug Alcohol Depend; 2014 Nov; 144():170-7. PubMed ID: 25263262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiles of recovery from alcohol use disorder at three years following treatment: can the definition of recovery be extended to include high functioning heavy drinkers?
    Witkiewitz K; Wilson AD; Pearson MR; Montes KS; Kirouac M; Roos CR; Hallgren KA; Maisto SA
    Addiction; 2019 Jan; 114(1):69-80. PubMed ID: 30063267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Validation of Reduced Alcohol Consumption After Treatment for Alcohol Dependence Using the World Health Organization Risk Drinking Levels.
    Witkiewitz K; Hallgren KA; Kranzler HR; Mann KF; Hasin DS; Falk DE; Litten RZ; O'Malley SS; Anton RF
    Alcohol Clin Exp Res; 2017 Jan; 41(1):179-186. PubMed ID: 28019652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can Individuals With Alcohol Use Disorder Sustain Non-abstinent Recovery? Non-abstinent Outcomes 10 Years After Alcohol Use Disorder Treatment.
    Witkiewitz K; Wilson AD; Roos CR; Swan JE; Votaw VR; Stein ER; Pearson MR; Edwards KA; Tonigan JS; Hallgren KA; Montes KS; Maisto SA; Tucker JA
    J Addict Med; 2021 Jul-Aug 01; 15(4):303-310. PubMed ID: 33060466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are non-abstinent reductions in World Health Organization drinking risk level a valid treatment target for alcohol use disorders in adolescents with ADHD?
    Mitchell HM; Park G; Hammond CJ
    Addict Behav Rep; 2020 Dec; 12():100312. PubMed ID: 33364320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower Prefrontal and Hippocampal Volume and Diffusion Tensor Imaging Differences Reflect Structural and Functional Abnormalities in Abstinent Individuals with Alcohol Use Disorder.
    Pandey AK; Ardekani BA; Kamarajan C; Zhang J; Chorlian DB; Byrne KN; Pandey G; Meyers JL; Kinreich S; Stimus A; Porjesz B
    Alcohol Clin Exp Res; 2018 Oct; 42(10):1883-1896. PubMed ID: 30118142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.